How therapeutics can help Michigan’s COVID cases
MDHHS to expand the use of medical intervention to reduce hospitalizations
Frank McGeorge, MD, Local 4 s Good Health Medical Expert
Tags:
April 14, 2021:
Some of these treatments aren’t new and have actually be in use for a while.
For example, the monoclonal antibody treatments aren’t new at all. As COVID cases have increased in the current wave, Michigan should prioritize treatment.
There are many people who are eligible for monoclonal antibody treatments who either aren’t being offered it or don’t know to ask about it.
The most ideal candidates to receive these treatments are people testing positive for coronavirus and have certain risk factors like being over 65 years old, diabetes, obesity or a combination of risk factors if they are younger than 65.
Johnson & Johnson s COVID-19 vaccine gets CDC panel backing, nearly ready for shipping theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
CDC Panel: No COVID-19 Vaccine Safety Surprises
Jan. 27, 2021 The U.S. is nearly 6 weeks into its historic campaign to vaccinate Americans against the virus that causes COVID-19, and so far, the two vaccines in use look remarkably low-risk, according to new data presented today at a meeting of vaccine experts that advise the CDC.
With 23.5 million doses of the Pfizer and Moderna vaccines now given, there have been very few serious side effects. In addition, deaths reported after people got the vaccine do not seem to be related to it.
The most common symptoms reported after vaccination were pain where people got the shot, fatigue, headache, and muscle soreness. These were more common after the second dose. In addition, about 1 in 4 people reported fever and chills after the second shot.